Download these slides for an expert review of novel therapies, improved adherence, and reducing health disparities in the management of moderate to severe psoriasis
This program is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Novartis Pharmaceuticals Corporation; and Sanofi and Regeneron Pharmaceuticals.
Steven Feldman, MD, PhD: consultant/speaker: AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Forte, Helsinn, Janssen, Leo, Lilly, Mylan, Novartis, Pfizer, Samsung, Sanofi, Sun, UCB, vTv Therapeutics, Voluntis; researcher: Galderma, Janssen, Lilly, Pfizer, Regeneron; stock/stock options: Sensal Health.
Melodie S. Young, MSN, RN, ANP-C: consultant/advisor/speaker: AbbVie, Amgen, Arcutis, Boehringer Ingelheim, Janssen, Leo, Lilly, Novartis, UCB.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 105822D-PPT4